Dept of Surgery, Cancer Center Amsterdam, Academic Medical Center, Amsterdam, The Netherlands; Dept of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.
Dept of Surgery, Cancer Center Amsterdam, Academic Medical Center, Amsterdam, The Netherlands.
HPB (Oxford). 2018 Oct;20(10):881-887. doi: 10.1016/j.hpb.2018.03.017. Epub 2018 Apr 26.
Radical resection of advanced pancreatic cancer may occasionally require a simultaneous colon resection. The risks and benefits of this combined procedure are largely unknown. This systematic review aimed to assess short and long term outcome after pancreatoduodenectomy with colon resection (PD-colon) for pancreatic ductal adenocarcinoma (PDAC).
A systematic literature search was performed in PubMed, Embase, and the Cochrane Library for studies published between 1994 and 2017 concerning PD-colon for PDAC.
After screening 2038 articles, 5 articles with a total of 181 patients undergoing PD-colon were eligible for inclusion. Included studies showed a relatively low risk of bias. The pooled complication rate was 73% (95% CI 61-84) including a pooled colonic anastomotic leak rate of 5.5%. Pooled mortality was 10% (95% CI 6-15). Pooled mean survival (data from 86 patients) was 18 months (95% CI 13-23) with pooled 3- and 5-year survival of 31% (95% CI 20-72) and 19% (95% CI 6-38).
Based on the available data, PD-colon for PDAC seems to be associated with an increased morbidity and mortality but with survival comparable with standard PD in selected patients. Future large series are needed to allow for better patient selection for PD-colon.
根治性切除晚期胰腺癌有时可能需要同时进行结肠切除术。这种联合手术的风险和益处尚不清楚。本系统评价旨在评估胰十二指肠切除术联合结肠切除术(PD-colon)治疗胰腺导管腺癌(PDAC)的短期和长期疗效。
在 PubMed、Embase 和 Cochrane 图书馆中,对 1994 年至 2017 年间发表的关于 PD-colon 治疗 PDAC 的研究进行了系统文献检索。
经过筛选 2038 篇文章后,有 5 篇文章共 181 例患者符合纳入标准。纳入的研究显示出相对较低的偏倚风险。汇总的并发症发生率为 73%(95% CI 61-84),其中结肠吻合口漏的汇总发生率为 5.5%。汇总死亡率为 10%(95% CI 6-15)。从 86 例患者中得出的汇总平均生存时间为 18 个月(95% CI 13-23),汇总 3 年和 5 年生存率分别为 31%(95% CI 20-72)和 19%(95% CI 6-38)。
根据现有数据,PD-colon 治疗 PDAC 似乎与发病率和死亡率增加相关,但在选定患者中与标准 PD 的生存情况相当。需要进一步的大型系列研究来更好地为 PD-colon 患者进行选择。